Authors:
Funato, K
Imai, T
Nakashima, K
Otagiri, M
Citation: K. Funato et al., High-performance liquid chromatography with chemiluminescence detection ofpenbutolol and its hydroxylated metabolite in rat plasma, J CHROMAT B, 757(2), 2001, pp. 229-235
Citation: Js. Zhang et al., Stability of a cisplatin-chondroitin sulfate A complex in plasma and kidney in terms of protein binding, BIOL PHAR B, 24(8), 2001, pp. 970-972
Authors:
Takusagawa, Y
Otagiri, M
Ui, S
Ohtsuki, T
Mimura, A
Ohkuma, M
Kudo, T
Citation: Y. Takusagawa et al., Purification and characterization of L-2,3-butanediol dehydrogenase of Brevibacterium saccharolyticum C-1012 expressed in Escherichia coli, BIOS BIOT B, 65(8), 2001, pp. 1876-1878
Authors:
Otagiri, M
Kurisu, G
Swaminathan, S
Ui, S
Yoneda, S
Ohkuma, M
Kudo, T
Kusunoki, M
Citation: M. Otagiri et al., Crystallization and preliminary X-ray studies of meso-2,3-butanediol dehydrogenase from Klebsiella pneumoniae IAM1063, ACT CRYST D, 57, 2001, pp. 857-859
Authors:
Sakai, T
Yamasaki, K
Sako, T
Kragh-Hansen, U
Suenaga, A
Otagiri, M
Citation: T. Sakai et al., Interaction mechanism between indoxyl sulfate, a typical uremic toxin bound to site II, and ligands bound to site I of human serum albumin, PHARM RES, 18(4), 2001, pp. 520-524
Authors:
Watanabe, H
Kragh-Hansen, U
Tanase, S
Nakajou, K
Mitarai, M
Iwao, Y
Maruyama, T
Otagiri, M
Citation: H. Watanabe et al., Conformational stability and warfarin-binding properties of human serum albumin studied by recombinant mutants, BIOCHEM J, 357, 2001, pp. 269-274
Citation: Vtg. Chuang et M. Otagiri, Flunitrazepam, a 7-nitro-1,4-benzodiazepine that is unable to bind to the indole-benzodiazepine site of human serum albumin, BBA-PROT ST, 1546(2), 2001, pp. 337-345
Authors:
Imamura, Y
Uchida, A
Takada, H
Otagiri, M
Tsuchiya, K
Citation: Y. Imamura et al., Strain-, sex- and species-related differences of acetohexamide reductase and 20 beta-hydroxysteroid dehydrogenase activities in liver microsomes of experimental animals, YAKUGAKU ZA, 121(1), 2001, pp. 85-91
Authors:
Otagiri, M
Kurisu, G
Ui, S
Takusagawa, Y
Ohkuma, M
Kudo, T
Kusunoki, M
Citation: M. Otagiri et al., Crystal structure of meso-2,3-butanediol dehydrogenase in a complex with NAD(+) and inhibitor mercaptoethanol at 1.7 angstrom resolution for understanding of chiral substrate recognition mechanisms, J BIOCHEM, 129(2), 2001, pp. 205-208
Authors:
Shimoishi, K
Kai, H
Kabu, K
Komori, T
Maruyama, T
Otagiri, M
Citation: K. Shimoishi et al., FK506 (tacrolimus) increases rat alpha(1)-acid glycoprotein expression in liver and primary cultured hepatocytes, EUR J PHARM, 420(2-3), 2001, pp. 91-95
Authors:
Komori, T
Kai, H
Shimoishi, K
Kabu, K
Nonaka, A
Maruyama, T
Tamura, K
Otagiri, M
Citation: T. Komori et al., Up-regulation by clarithromycin of alpha(1)-acid glycoprotein expression in liver and primary cultured hepatocytes, BIOCH PHARM, 62(10), 2001, pp. 1391-1397
Authors:
Harada, D
Naito, S
Kawauchi, Y
Ishikawa, K
Koshitani, O
Hiraoka, I
Otagiri, M
Citation: D. Harada et al., Determination of reduced, protein-unbound, and total concentrations of N-acetyl-L-cysteine and L-cysteine in rat plasma by postcolumn ligand substitution high-performance liquid chromatography, ANALYT BIOC, 290(2), 2001, pp. 251-259
Citation: T. Imai et al., Biological properties of low molecular fragmented gelatine and its evaluation as a rapid absorptive additive in human volunteers, STP PHARM S, 10(4), 2000, pp. 321-326
Citation: T. Imai et al., A strategy for the immediate-release of indomethacin from a sustained-release preparation using a chitosan hydrolysate, STP PHARM S, 10(1), 2000, pp. 57-62
Authors:
Kurata, N
Matsushita, S
Nishi, K
Watanabe, H
Kobayashi, S
Suenaga, A
Otagiri, M
Citation: N. Kurata et al., Characterization of a binding site of UCN-01, a novel anticancer drug on alpha(1)-acid glycoprotein, BIOL PHAR B, 23(7), 2000, pp. 893-895
Authors:
Imamura, Y
Koga, T
Uriu, Y
Otagiri, M
Satoh, K
Hara, A
Citation: Y. Imamura et al., Catalytic properties for naphthoquinones and partial primary structure of rabbit heart acetohexamide reductase, BIOL PHAR B, 23(2), 2000, pp. 155-158
Citation: Js. Zhang et al., Effects of a cisplatin-chondroitin sulfate A complex in reducing the nephrotoxicity of cisplatin, ARCH TOXIC, 74(6), 2000, pp. 300-307
Authors:
Watanabe, H
Tanase, S
Nakajou, K
Maruyama, T
Kragh-Hansen, U
Otagiri, M
Citation: H. Watanabe et al., Role of Arg-410 and Tyr-411 in human serum albumin for ligand binding and esterase-like activity, BIOCHEM J, 349, 2000, pp. 813-819
Authors:
Imai, T
Kawasaki, C
Nishiyama, T
Otagiri, M
Citation: T. Imai et al., Comparison of the pharmaceutical properties of sustained-release gel beadsprepared by alginate having different molecular size with commercial sustained-release tablet, PHARMAZIE, 55(3), 2000, pp. 218-222
Authors:
Tsutsumi, Y
Maruyama, T
Takadate, A
Shimada, H
Otagiri, M
Citation: Y. Tsutsumi et al., Decreased bilirubin-binding capacity in uremic serum caused by an accumulation of furan dicarboxylic acid, NEPHRON, 85(1), 2000, pp. 60-64
Authors:
Takada, H
Uchida, A
Kamizono, R
Otagiri, M
Imamura, Y
Citation: H. Takada et al., Further studies on 20 beta-hydroxysteroid dehydrogenase with carbonyl reductase-like activity present in liver microsomes of male rats, LIFE SCI, 67(17), 2000, pp. 2075-2082
Authors:
Yamada, T
Imai, T
Ouchi, K
Otagiri, M
Hirayama, F
Uekama, K
Citation: T. Yamada et al., Inclusion complex of 3,9-bis(N,N-dimethylcarbamoyloxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) with heptakis(2,6-di-O-methyl)-beta-cyclodextrin:Interaction and dissolution properties, CHEM PHARM, 48(9), 2000, pp. 1264-1269